#34 - Cary Claiborne, CEO of Adial Pharmaceuticals
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us on the latest episode! Our Guest: Cary Claiborne, CEO of Adial Pharmaceuticals.
What you'll get out of this episode:
- Meet Cary Claiborne: Discover the visionary CEO behind Adial Pharmaceuticals.
- Understanding AD04: Dive into the science of this promising new treatment for alcohol use disorder.
- The Impact of Alcohol Use Disorder: A closer look at the challenges and the need for better treatments.
- A Glimpse into the Future: Explore how AD04 could revolutionize addiction treatment beyond alcohol use disorder.
- Adial's Mission and Vision: Hear directly from Claiborne about the company's path forward and commitment to innovation.
To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/cary-claiborne-sr-84a2217/
Company LinkedIn: https://www.linkedin.com/company/adialpharma/
Website: https://www.adial.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/